Hristo Metev

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial

Yves Dauvilliers, Johan Verbraecken, Markku Partinen et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 263 citations · Full text

Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial

Paul M. O’Byrne, Hristo Metev, Margareta Puu et al. · The Lancet Respiratory Medicine · 2016 · 256 citations

Asthma, Cxcr2 Antagonist, Allergy +7

Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

Menno D. de Jong, Michael G. Ison, Arnold S. Monto et al. · Clinical Infectious Diseases · 2014 · 112 citations

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Carlos M. Barrera, Analía Mykietiuk, Hristo Metev et al. · The Lancet Infectious Diseases · 2016 · 100 citations

Antimicrobial Stewardship, Antibiotics, Community-acquired Bacterial Pneumonia +8